DSP Healthcare Fund - Regular Plan - Growth
💡 Why Pick This Fund? Quantitative Strengths & Watch-outs
- Outperformed category benchmark in 69% of historical 3-year rolling periods.
- Strong capital defense: downside capture of 53% limits losses during market corrections.
- Generated +10.5% annualized alpha (excess return) over its benchmark.
- Cost-efficient: expense ratio of 2.04% is lower than category median (2.52%).
- Equities carry market risk; returns fluctuate and recommended investment horizon is 5+ years.
Key Statistics vs Category Median
Trailing Returns Comparison
| Period | Fund Return | Category Median | Difference |
|---|---|---|---|
| 1 Month | +6.82% | +6.32% | +0.50% |
| 3 Months | +2.97% | -0.20% | +3.17% |
| 6 Months | +17.73% | +5.98% | +11.75% |
| 1 Year | +18.08% | +3.90% | +14.18% |
| 3 Years CAGR | +20.31% | +13.23% | +7.08% |
| 5 Years CAGR | +15.84% | +10.72% | +5.12% |
| 7 Years CAGR | +23.74% | +15.35% | +8.39% |
| Since Inception | +21.46% | - | - |
📈 Monthly SIP vs Bank Fixed Deposit (FD) Replay
See how a regular monthly SIP in DSP Healthcare Fund compares against a standard 7.0% p.a. Bank Fixed Deposit.
Calendar Year Returns
| Year | Fund | Category Median | Gap |
|---|---|---|---|
| 2026 | +20.01% | +4.03% | +15.98% |
| 2025 | -5.81% | +1.43% | -7.24% |
| 2024 | +40.69% | +20.41% | +20.28% |
| 2023 | +35.00% | +30.70% | +4.30% |
| 2022 | -7.79% | +1.66% | -9.45% |
| 2021 | +23.30% | +30.31% | -7.01% |
| 2020 | +76.90% | +13.54% | +63.36% |
| 2019 | +7.69% | +7.11% | +0.58% |
Daily Rolling Returns Summary
| Rolling Window | Minimum | Average | Median | Maximum | % Positive | % Beating Proxy |
|---|---|---|---|---|---|---|
| 1-Year Rolling | -15.21% | +24.87% | +18.62% | +94.07% | 79.0% | 55.5% |
| 3-Year Rolling | +13.36% | +21.93% | +21.15% | +32.90% | 100.0% | 68.6% |
| 5-Year Rolling | +12.71% | +22.04% | +23.41% | +33.61% | 100.0% | 64.2% |
Risk Profile & Deepest Drawdowns
Deepest Market Corrections (Depth >= 10%)
| Peak Date | Trough Date | Fall Depth | Months to Bottom | Recovery Period |
|---|---|---|---|---|
| 2021-09-15 | 2022-06-17 | -22.1% | 9 months | 13 months |
| 2020-02-20 | 2020-03-23 | -21.9% | 1 months | 1 months |
| 2025-01-07 | 2025-04-07 | -16.4% | 3 months | 15 months |
Portfolio & Asset Allocation
Statutory Asset Allocation Mandate (SEBI / SID)
| Instrument Category | Permitted Allocation Range |
|---|---|
| 1.Equity and Equity related Instruments of Pharmaceutical and Healthcare companies / entities | 80% - 100% 2. Other Equity and Equity related Instruments/ Money Market Instruments / InvITs/ Gold ETFs / Silver ETFs / Other Liquid Instruments / Units of Domestic Mutual Funds^: 0% - 20% For detailed asset allocation pattern, please refer to the Scheme Information Document^Any other security as may be permitted by SEBI/ RBI from time to time. Other Liquid instruments includes cash, bank deposits with Scheduled Commercial Banks, Government Securities, Treasury bills, Repo on Government securities and any other instruments as specified by the SEBI. The scheme may invest in the units of Overnight Fund, Money Market Fund & Liquid Fund (including Liquid ETFs) of Domestic Mutual Fund. |
Investment Objective & Strategy
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies/entities. There is no assurance that the investment objective of the Scheme will be achieved.
ℹ️ Detailed monthly stock-level holdings for this scheme are updated periodically from asset management company statutory disclosures.
Fund Size Position
Currently managing Rs 3,946 cr (AMFI Daily Fund AUM as of 2026-11-11). Positioned as stretched relative to Sectoral / Thematic schemes.
Fund Management
Cost & Capital Gains Taxation
From April 2026 the total expense ratio includes brokerage, transaction costs and statutory levies on top of the base fee.
Equity-oriented schemes: 20% short-term capital gains tax if sold within 12 months; 12.5% long-term capital gains tax on gains exceeding ₹1.25 lakh per financial year when held for more than 12 months.
Closest Sectoral / Thematic Peers by Rank
| Scheme | Score | 3Y Return | Expense | Downside | Fund Size | Compare |
|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity fund | 7.2 | +45.47% | 2.39% | -77.2% | Rs 806 cr | Compare → |
| Aditya Birla Sun Life International Equity Fund | 5.8 | +20.53% | 2.55% | -28.3% | Rs 337 cr | Compare → |
| Mirae Asset Healthcare Fund | 7.9 | +22.67% | - | 45.7% | Rs 3,828 cr | Compare → |
| Aditya Birla Sun Life Pharma and Healthcare Fund | 7.4 | +19.30% | 2.27% | 50.0% | Rs 1,154 cr | Compare → |
| UTI Healthcare Fund | 7.0 | +22.74% | 2.20% | 57.0% | Rs 1,536 cr | Compare → |
Frequently Asked Questions about DSP Healthcare Fund
What is the expense ratio of DSP Healthcare Fund?
DSP Healthcare Fund has a total expense ratio (TER) of 2.04% with a base expense ratio of 1.63%, compared to the Sectoral / Thematic category median of 2.52%.
Who manages DSP Healthcare Fund?
DSP Healthcare Fund is managed by Chirag Dagli.
What are the historical returns of DSP Healthcare Fund?
DSP Healthcare Fund delivered a 3-year CAGR of 20.31% and a 5-year CAGR of 15.84%. Its 1-year return stands at +18.08%.
How large is DSP Healthcare Fund?
DSP Healthcare Fund manages assets of Rs 3,946 cr, placing it in the 'stretched' size band relative to Sectoral / Thematic peers.
How is DSP Healthcare Fund scored on MFIQ?
DSP Healthcare Fund holds an MFIQ Score of 8.0/10 (Good), based on a category percentile composite across returns, risk, consistency, and cost.
How risky is DSP Healthcare Fund?
DSP Healthcare Fund has an official SEBI riskometer rating of Very High. Over the analyzed period, its annualized standard deviation is 13.01% with a maximum historical drawdown of -22.08%.